RBC Cuts 4basebio PT, Maintains Outperform Rating

MT Newswires · 2d ago
08:33 AM EDT, 09/28/2026 (MT Newswires) -- RBC on Monday reduced its price target for synthetic DNA manufacturer 4basebio (4BB.L) to 10 pounds sterling from 14 pounds and maintained its outperform rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)